基本信息
views: 3
Career Trajectory
Bio
Dr. Wagner’s research focuses on real-time methods for detecting and characterizing disease outbreaks, including the development and testing of operational biosurveillance systems. In his role as director of the RODS Laboratory, Dr. Wagner led the development and implementation of two widely used biosurveillance systems: the RODS system and the National Retail Data Monitor (NRDM).
Biosurveillance is a systematic process that detects and characterizes disease outbreaks. The process involves data collection, analysis, and decision making. The purpose of biosurveillance is to determine whether an outbreak exists, and if so, to identify the biological agent, source, route of transmission, geographic extent, and other characteristics that influence decisions about antibiotics, vaccines, quarantine, and other responses.
At present, Dr. Wagner is developing a third system called BioEcon. BioEcon is a decision analytic tool for use by analysts working in health departments. BioEcon is a logical extension of Dr. Wagner’s research in biosurveillance. BioEcon addresses the problem of what is the optimal action to take in response to incoming biosurveillance data.
The success of Dr. Wagner’s research into methods to collect and analyze biosurveillance data have now produced a situation in which health departments have an abundance of biosurveillance data and face decisions about how to react to anomalies in those data.
Biosurveillance is a systematic process that detects and characterizes disease outbreaks. The process involves data collection, analysis, and decision making. The purpose of biosurveillance is to determine whether an outbreak exists, and if so, to identify the biological agent, source, route of transmission, geographic extent, and other characteristics that influence decisions about antibiotics, vaccines, quarantine, and other responses.
At present, Dr. Wagner is developing a third system called BioEcon. BioEcon is a decision analytic tool for use by analysts working in health departments. BioEcon is a logical extension of Dr. Wagner’s research in biosurveillance. BioEcon addresses the problem of what is the optimal action to take in response to incoming biosurveillance data.
The success of Dr. Wagner’s research into methods to collect and analyze biosurveillance data have now produced a situation in which health departments have an abundance of biosurveillance data and face decisions about how to react to anomalies in those data.
Research Interests
Papers共 159 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of biomedical informaticspp.104647-104647, (2024)
Journal of Biomedical Informaticsno. C (2024)
Michael M. Wagner,William R. Hogan,John Levander, Adam Darr, Matt Diller, Max Sibilla,Alexander T. Loiacono, Terence Sperringer Jr.,Shawn T. Brown
CoRR (2023)
Christopher L Moore, Jing Wang, Anthony J Battisti,Alvin Chen,Jonathan Fincke, Anita Wang,Michael Wagner,Balasundar Raju,Cristiana Baloescu
Blake Saul, Elise Ketelaar, Amjad Yaish,Michael Wagner, Robert Comrie,Grace D Brannan,Carolina Restini, Michelle Balancio
Spartan medical research journalno. 2 (2022): 36719-36719
Load More
Author Statistics
#Papers: 160
#Citation: 6103
H-Index: 41
G-Index: 73
Sociability: 6
Diversity: 1
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn